Harmonization of Standards under the EU MDR

by | Sep 6, 2019 | EU, EU MDR, FDA, Medical Devices, Regulatory, Requirements

The new EU MDR and the new IVDR have some harmonized standards also known as recognized standards. The harmonized standards are those that are referenced in the Official Journal of the European Union. Devices that comply with these harmonized standards are considered to be in compliance with the MDR and IVDR.

The conformity may be to the quality system as a whole or just specific component like risk management system, post-market surveillance system, clinical investigation or evaluations. For a standard to be harmonized with the MDR and IVDR, a standardization request has to be agreed upon between the European Commission and the European Standards Organizations.

The draft standardization request lists the standards to be revised and the deadline for their adoption. Some standards have a higher priority for adoption. Most of these high priority standards are the ones that apply to a wide range of manufacturers.

Some standards that suppo­rt the MDR with a deadline of adoption of May 2020 are:1

  • EN ISO 13485 – Medical devices – Quality management systems – Requirements for regulatory purposes
  • EN ISO 14971- Medical devices – Application of risk management to medical devices.
  • EN ISO 14155 – Clinical investigation of medical devices for human subjects – Good clinical practice;
  • EN ISO 15223-1 – Medical devices – Symbols to be used with medical device labels, labeling and information to be supplied – Part 1: General requirements;
  • EN 15986 – Symbol for use in the labeling of medical devices – Requirements for labeling of medical devices containing phthalates.

For the MDR, in addition to the above, there are 63 new or revised standards identified with the longer deadline for adoption of 27 May 2024. These include standards for:1

  • Validation and routine control of sterilization and aseptic processing;
  • Packaging for sterile devices;
  • Biological evaluation;
  • Devices using tissues of animal origin;
  • Medical electrical equipment;
  • Device software;
  • Usability engineering.

Many standards committees are already working on amending or revising the standards in their areas of responsibility. The processes of revising EN ISO 14971 and amending EN ISO 13485 are underway. It will be interesting to know what other standards get incorporated into the harmonized standards list of the EU MDR.

Want to market your device in the EU? Do you need help complying with the new EU MDR? Contact us at 248-987-4497 or email us at info@emmainternational.com.

1BSI (August 2019) Harmonization of standards under the regulations for medical devices moves forward slowly retrieved on 08/28/2019 from https://compliancenavigator.bsigroup.com/en/medicaldeviceblog/harmonization-of-standards-under-the-regulations-for-medical-devices-moves-forward-slowly/?utm_source=pardot&utm_medium=email&utm_campaign=SM-SUB-LG-HLTH-CN_blog-2019

Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

FDA Adverse Event Reporting 

FDA Adverse Event Reporting 

When reporting an Adverse Event to the Food and Drug Administration (FDA) the best method is to utilize the FDA Adverse Event Reporting System (FAERS). FAERS is a database that contains adverse event reports, product quality complaints that led to an adverse event, and medication error reports1. All FAERS reports are easily accessible to the public. 
De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.

Ready to learn more about working with us?

Pin It on Pinterest

Share This